Team develops new tool, LumosVar, for discerning genetic variants; more genomic sequencing needed for clinical application to cancer patients.
When pushing the boundaries of discovery, sometimes even the most experienced of scientists can get a surprise jolt from a completely unpredictable result.
With smartphones millions of times more powerful than the NASA Apollo computers that sent us to the moon in the 1960s, scientists have been eager to adapt them back here on Earth to better the planet.
Two patents have been awarded to the UA based on the novel approach of ProNeurogen to treating diseases causing memory loss and cognitive impairment.
The US Food and Drug Administration has awarded the Institute for Advanced Clinical Trials for Children (I-ACT for Children) a grant to improve clinical trials of new drugs and devices for children. The award establishes an alliance among I-ACT for Children and PEDSnet, the James M. Anderson Center for Health Systems Excellence, Critical Path Institute and the National Capital Consortium for Pediatric Device Innovation, to work together with leading children’s institutions and health systems to address key gaps and challenges in pediatric clinical trials.
What if you could experience full health until the very end of your life? UA researchers, led by Dr. Janko Nikolich-Zugich, think long-lasting immunity from disease might be possible — if the thymus and the T-cells it produces to fight infection can be brought back to work efficiently.
U.S. Centers for Disease Control announces creation of pilot projects geared to protect public health
